Detalhe da pesquisa
1.
Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study.
Am J Obstet Gynecol
; 226(1): 97.e1-97.e16, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461074
2.
A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway.
Am J Obstet Gynecol
; 224(1): 70.e1-70.e11, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682856
3.
Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway.
Int J Gynecol Cancer
; 31(4): 569-574, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483432
4.
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Blood
; 132(10): 1013-1021, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049811
5.
Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs.
Am J Obstet Gynecol
; 222(1): 66.e1-66.e9, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376395
6.
Enhanced recovery for obese patients undergoing gynecologic cancer surgery.
Int J Gynecol Cancer
; 30(10): 1595-1602, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848023
7.
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Br J Haematol
; 185(1): 53-64, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723894
8.
Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases.
Gynecol Oncol
; 152(1): 101-105, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396690
9.
Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery.
Int J Gynecol Cancer
; 29(9): 1417-1424, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601647
10.
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.
Blood
; 128(21): 2510-2516, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697771
11.
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
Breast Cancer Res Treat
; 163(2): 391-398, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283904
12.
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).
Cancer
; 122(22): 3555-3563, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27447359
13.
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
Breast Cancer Res Treat
; 139(2): 607-16, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23681403
14.
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
Breast Cancer Res Treat
; 138(2): 457-66, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23423445
15.
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
Am J Surg Pathol
; 45(3): 384-393, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33136585
16.
Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial.
Lancet Haematol
; 7(6): e490-e497, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32470440
17.
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.
Cancer Med
; 8(1): 165-173, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575311
18.
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
J Clin Oncol
; 37(21): 1790-1799, 2019 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30939090
19.
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
Clin Cancer Res
; 24(6): 1486-1499, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311117
20.
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Clin Cancer Res
; 24(21): 5292-5304, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037817